PD-L1 status in refractory lymphomas

被引：0
|
作者：
Vranic, S. [1 ]
Jin, J. [2 ]
Kimbrough, J. [3 ]
Ghosh, N. [4 ]
Bilalovic, N. [1 ]
Arguello, D. [3 ]
Veloso, Y. [3 ]
Hendershot, T. [2 ]
Dizdarevic, A. [5 ]
Reddy, S. [3 ]
Gatalica, Z. [3 ]
机构：
[1] Univ Sarajevo, Ctr Clin, Pathol, Sarajevo, Bosnia & Herceg
[2] Agilent Technol, Pathol, Santa Clara, CA USA
[3] Caris Life Sci, Pathol, Phoenix, AZ USA
[4] Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA
[5] Univ Sarajevo, Ctr Clin, Hematol, Sarajevo, Bosnia & Herceg
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw375.16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
921P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PD-L1 Status in Refractory Lymphomas
    Vranic, Semir
    Ghosh, Nilanjan
    Kimbrough, Jeffery
    Bilalovic, Nurija
    Bender, Ryan
    Arguello, David
    Veloso, Yvonne
    Dizdarevic, Aida
    Gatalica, Zoran
    PLOS ONE, 2016, 11 (11):
  • [2] PD-L1 and PD1 Expression in Lymphomas
    Gatalica, Zoran
    Bilalovic, Nurija
    Vranic, Semir
    Arguello, David
    Reddy, Sandeep
    Ghosh, Nilanjan
    BLOOD, 2015, 126 (23)
  • [3] Clinical PD-1/PD-L1 Blockades in Combination Therapies for Lymphomas
    Katsuya, Hiroo
    Suzumiya, Junji
    Kimura, Shinya
    CANCERS, 2023, 15 (22)
  • [4] Prognostic value of PD-L1 status
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2016, 13 (12) : 694 - 694
  • [5] Prognostic value of PD-L1 status
    Clemens Thoma
    Nature Reviews Urology, 2016, 13 : 694 - 694
  • [6] Heterogeneity and Geographical Patterns of PD-L1 Expression in Colonic Adenocarcinoma with Discordant PD-L1 Status
    Messersmith, Lynn
    Williams, Grant
    Bohan, Phillip Kemp
    Chick, Robert
    Broadwater, Devin
    Lombardo, Jamie
    Hickerson, Annelies
    Cindass, Jessica
    Brady, Robert
    Peoples, George
    Clifton, Guy
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 716 - 717
  • [7] Heterogeneity and Geographical Patterns of PD-L1 Expression in Colonic Adenocarcinoma with Discordant PD-L1 Status
    Messersmith, Lynn
    Williams, Grant
    Bohan, Phillip Kemp
    Chick, Robert
    Broadwater, Devin
    Lombardo, Jamie
    Hickerson, Annelies
    Cindass, Jessica
    Brady, Robert
    Peoples, George
    Clifton, Guy
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 716 - 717
  • [8] Expression of PD-1/PD-L1 in children's classical Hodgkin lymphomas
    Dilly-Feldis, Marie
    Aladjidi, Nathalie
    Refait, John K.
    Parrens, Marie
    Ducassou, Stephane
    Rullier, Anne
    PEDIATRIC BLOOD & CANCER, 2019, 66 (05)
  • [9] Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
    Shen, Xian
    Zhao, Bin
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [10] PD-L1 expression in peripheral T-cell lymphomas is not related to either PD-L1 gene amplification or rearrangements
    Manso, Rebeca
    Rodriguez-Perales, Sandra
    Torres-Ruiz, Raul
    Santonja, Carlos
    Rodriguez-Pinilla, Socorro-Maria
    LEUKEMIA & LYMPHOMA, 2021, 62 (07) : 1648 - 1656
12345